One Case of Ovarian Cancer Biochemical Recurrence Treated by Wenyang Huaji Method
增强出版
1.Department of Oncology, Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, 101300, China.
2.Department of Oncology, Beijing Hospital of Traditional Chinese Medicine affiliated with Capital Medical University, Beijing, 100010, China
DOI:
扫 描 看 全 文
Haining YANG, Wenjing YANG, Yuyi CHEN, et al. One Case of Ovarian Cancer Biochemical Recurrence Treated by Wenyang Huaji Method[DB/OL].(2022-08-04)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29013953&Fpath=home&index=0
DOI:
Haining YANG, Wenjing YANG, Yuyi CHEN, et al. One Case of Ovarian Cancer Biochemical Recurrence Treated by Wenyang Huaji Method[DB/OL].(2022-08-04)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29013953&Fpath=home&index=0DOI:
One Case of Ovarian Cancer Biochemical Recurrence Treated by Wenyang Huaji Method增强出版
One patient with biochemical recurrence of ovarian cancer was treated with Wenyang Huaji method. ,Summary of case history, The patient was an elderly woman, whose the chief complaint was "5 years after surgery for ovarian cancer and 2 years after surgery for recurrence". The patient underwent surgical treatment for ovarian mass in June 2016. Postoperative pathology is ovarian serous papillary cystic carcinoma, stage ⅢC, which is locally advanced. Six cycles of chemotherapy were performed after surgery, and Chinese medicine was used during the period. After that, regular review and evaluation results were stable. In August 2019, the CA125 was 43.5U/ml , and CT of the lower abdomen and pelvis showed that the right lower peritoneal nodule was significantly larger than before, and tumor recurrence was considered. In September 2019, the patient underwent peritoneal metastasis debulking again. And 6 cycles of consolidation chemotherapy were performed postoperatively. The CA125 after chemotherapy was 5 U/mL. After that, the imaging and CA125 were regularly reviewed and no obvious progress was found. The CA125 was 13.4 U/mL in February 2021, no obvious signs of recurrence on imaging of lower abdomen + pelvic enhanced CT. Then the CA125 gradually increased. The CA125 was 22.9 U/ml in June 2021, and lower abdomen + pelvic CT showed pelvic cavity Nodular thickening of the peritoneum, but no obvious dynamic changes. Therefore, the possibility of biochemical recurrence of the patient was considered., Symptoms and signs, At the time of consultation, the patient had cold hands and feet, chills all over the body, and fever from time to time, which occurred once every 1-2 weeks on average. Physical strength is acceptable, sleepiness is acceptable, stool is not formed, once a day, urination is normal. The tongue is pale, dark and fat, with tooth marks on the sides, thin yellow and greasy fur, and slippery pulse.,TCM disease and syndrome:, abdominal mass (positive deficiency and toxin syndrome). ,Western medicine diagnosis:, ovarian malignant tumor. TCM treatment is based on warming yang and eliminating accumulation, with the products of removing blood stasis and detoxification. ,Clinical outcomes, After the treatment, the patient's hands and feet were significantly improved, and the frequency of exogenous chills and fever symptoms gradually decreased to disappear. At the same time, physical strength and diet were also improved, which significantly improved the patient's quality of life. During the review in September of the same year, the CA125 also showed a downward trend, and the CA125 in the review in October had dropped to the normal range. Since the biochemical recurrence of this patient, the traditional Chinese medicine treatment has achieved remarkable curative effect, which not only relieves the symptoms but also effectively controls the recurrence and progression of the tumor.
关键词
卵巢癌中医药生化复发温阳化积法肿瘤
Keywords
Ovarian cancerTraditional Chinese MedicineBiochemical recurrenceWenyang Huaji methodtumor
references
Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(4):284-296.
Wikborn C., Pettersson F., Moberg P. J.. Delay in diagnosis of epithelial ovarian cancer[J]. International Journal of Gynecology and Obstetrics, 1996, 52(3):263-267.
Rufford B.D., Jacobs I.J., Menon U. Feasibility of screening for ovarian cancer using symptoms as selection criteria [J]. British Journal of Obstetrics and Gynaecology, 2007,114(1):59-64.